SignatureFD’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-64,700
Closed -$28.6K 3430
2023
Q1
$28.6K Buy
64,700
+4,700
+8% +$1.84K ﹤0.01% 1676
2022
Q4
$13.2K Sell
60,000
-9,300
-13% -$2.78K ﹤0.01% 2009
2022
Q3
$25K Buy
69,300
+34,300
+98% +$23.4K ﹤0.01% 1644
2022
Q2
$23K Buy
35,000
+15,000
+75% +$9.96K ﹤0.01% 1707
2022
Q1
$16K Hold
20,000
﹤0.01% 1970
2021
Q4
$23K Hold
20,000
﹤0.01% 1733
2021
Q3
$50K Buy
+20,000
New +$55.5K ﹤0.01% 1304

Other funds holding CEMI

SignatureFD's CEMI Position: Q2 2023 in Review

SignatureFD sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 64,700 shares — an estimated $28.6K sold.

SignatureFD first reported a position in CEMI in Q3 2021 and held it in 7 quarters. The position peaked at $50K in Q3 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • SignatureFD reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • SignatureFD sold 64,700 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $28.6K.
  • SignatureFD first reported a position in Chembio diagnostics, Inc. in Q3 2021 and held it in 7 quarters.
  • SignatureFD's Chembio diagnostics, Inc. position peaked at $50K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.